Docusate Sodium And Sennosides Tablet
Product Images NDC 62993-0002
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Docusate Sodium And Sennosides (NDC 62993-0002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Morepen Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1000 Tablets Principle Display Panel (1000 Pdp)
This is a drug description for tablets containing Docusate Sodium and Sennosides, used as a stool softener and laxative to relieve occasional constipation. It provides warnings and directions for use based on age groups. The tablets have inactive ingredients and do not contain added colors. It is essential to seek medical advice before use when pregnant or breastfeeding. The product is comparable to Senokot™-S and offers gentle and dependable constipation relief. Contact information for inquiries or comments is provided. The drug is distributed by Morepen Bio Inc. and must not be used if the seal under the cap is missing or damaged.*
30 Tablets Principle Display Panel (30 Pdp)
3000 Tablets Principle Display Panel (3000 Pdp)
The text provides information about a medication with the active ingredients Docusate Sodium and Sennosides. It is a dual-action tablet that serves as a stool softener and a laxative. The medication is used to relieve occasional constipation and is designed to produce a bowel movement within 6-12 hours. The dosage instructions for adults and children are given, along with warnings about potential side effects and when to seek medical attention. The packaging contains 3000 tablets and includes details about inactive ingredients and storage recommendations. It is essential to consult a healthcare professional before use, especially if pregnant or breastfeeding. The text also states that the product is not manufactured or distributed by the company that owns the registered trademark Senokot™-S.*
60 Tablets Principle Display Panel (60 Pdp)
Active Ingredient Label (Active Ingredients)
Dosage & Administration (Dosage And Administration)
Inactive Ingredients Label (Inactive Ingredients)
This text lists the inactive ingredients present in a medication, including colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate, FD&C Yellow #5 Lake, FD&C Yellow #6 Lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, talc, and titanium dioxide. It also notes that FD&C Yellow #5 Lake (also known as tartrazine) is used as a color additive in the product.*
Indications & Usage (Indications And Usage)
Keep Out Of Reach Of Children (Keep Out Of Reach Of Children)
Storage And Handling (Other Information)
Purpose Label (Purpose)
This text is a drug facts label that provides information on the active ingredients in a medication. It includes Docusate sodium USP for stool softening and Sennosides 8.6 mg for its laxative properties. This medication likely helps with constipation by softening the stool and promoting bowel movements.*
Questions Section Label (Questions)
Warnings (Warning Docusate)
This is a set of warnings and instructions for a laxative product. It advises not to use the product with certain conditions like stomach pain, nausea, and vomiting. It also warns about certain symptoms that may indicate a serious condition such as rectal bleeding or failure to have a bowel movement after using the laxative. It is recommended to ask a doctor before using the product if pregnant or breastfeeding. In case of overdose, contacting a Poison Control Center is advised.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.